1 |
Onoue K, Ishihara S, Ogura M, Nakano T. Macrophage Phagocytes Amyloid Fibrils in Giant Cell Myocarditis. Intern Med 2023. [DOI: 10.2169/internalmedicine.1020-22] [Reference Citation Analysis]
|
2 |
Kreiniz N, Gertz MA. Bad players in AL amyloidosis in the current era of treatment. Expert Rev Hematol 2023;16:33-49. [PMID: 36620914 DOI: 10.1080/17474086.2023.2166924] [Reference Citation Analysis]
|
3 |
Yaneva Z, Ivanova D, Nikolova N, Toneva M. Organic dyes in contemporary medicinal chemistry and biomedicine. I. From the chromophore to the bioimaging/bioassay agent. Biotechnology & Biotechnological Equipment 2022;36:1-14. [DOI: 10.1080/13102818.2022.2039077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Jackson JW, Foster JS, Martin EB, Macy S, Wooliver C, Balachandran M, Richey T, Heidel RE, Williams AD, Kennel SJ, Wall JS. Collagen inhibits phagocytosis of amyloid in vitro and in vivo and may act as a 'don't eat me' signal. Amyloid 2022;:1-12. [PMID: 36541892 DOI: 10.1080/13506129.2022.2155133] [Reference Citation Analysis]
|
5 |
Lavatelli F. Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis. Hemato 2022;3:47-62. [DOI: 10.3390/hemato3010005] [Reference Citation Analysis]
|
6 |
Bianchi G, Kumar S. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases. Hematol Oncol Clin North Am 2020;34:1009-26. [PMID: 33099420 DOI: 10.1016/j.hoc.2020.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Kourelis TV, Villasboas JC, Jessen E, Dasari S, Dispenzieri A, Jevremovic D, Kumar S. Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies. Blood Cancer J 2019;9:72. [PMID: 31462637 DOI: 10.1038/s41408-019-0234-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|